Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2024-06-10 00:00:00 ET · period of report 2024-06-06 · accession 0001714899-24-000145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-10 | 2024-06-06 | DNLI | Cook Jennifer E. | Dir | S - Sale | $21.73 | -1,458 | 20.0K | -7% | -$31.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-06 | S | D | 1,458 | $21.73 | 20,038 | D | — | — | (F2) Includes 5,967 unvested RSUs. |